Idorsia
idorsia.com
Actively hiring
Biotechnology
Prescription Drugs
Health Care
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$350M
1 round on record
Latest round
$350M
Venture round · Feb 2024 · 2 yr ago
Team
201-500
employees, estimated range
The money's age
Long since its last round
31 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 27, 2024
Raised a round Venture round $350M
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Feb 2024 | $350M | — | fiercebiotech.com |
Investors in similar startupsfunds that back the companies most like this one
backs Cartography
Similar startupsby what they do, their industry and backers
Pharmanovia, the lifecycle management company, is committed to realising the full potential of established medicines.
We transform somatic genomics insights into potentially breakthrough medicines. Learn more at Quotient-Tx.com
Centessa Pharmaceuticals is a transformational pharmaceutical brand that aims to discover and develop medicines that can have a profound…
DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small…
Luxna Biotech is a preclinical-stage Japanese biotechnology company that develops antisense oligonucleotide (ASO) therapeutics using novel…
Mapping Biology to Precise Medicines The best therapeutics are built around the best targets. By analyzing massive datasets from individual…
News
Idorsia (SWX:IDIA) Stock Could Be Fully Priced On Current Sales
Idorsia has given investors a wild ride over the past few years, and the big question now is whether the current share price can be squared with the revenue the business is generating. With the stock having gone through both sharp gains and deep declines,
Read more
Report
Idorsia launches an offering of registered shares - to fund the company to overall profitability - Company Announcement - FT.com
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
Read more
Report
Idorsia's Tryvio deal collapses, forcing company to find cash urgently
With a potential buyer not working out, Idorsia has adjusted an existing partnership and restructured bonds to raise cash.
Read more
Report
Idorsia publishes an invitation to a bondholder meeting - Company Announcement - FT.com
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
Read more
Report
Idorsia, weeks from cash-tastrophe, bags $350M upfront from Viatris for 2 late-phase assets
Read more
Report
Show more news
Financials
Total raised
$350M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2024 | $350M | Details |